Tivozanib (Fotivda)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tivozanib (Fotivda), covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer [Phase 3]